Pharmapace — 38 certified H-1B filings (FY2016–FY2025)

2
Filings · FY2025
$98k
Median base · FY2025
Analyst/Programmer I
Top role · 8 all-time
CA
Top state · 35 all-time
FY

Pharmapace filed 2 certified H-1B LCAs in FY2025 (down 80% from the year before), with a median base salary of $98k and the middle 50% of offers between $98k and $110k. That is 11% below the market median for the same job titles. Across all years it has 38 certified filings since FY2016, most often for Analyst/Programmer I in California.

How much does Pharmapace pay H-1B workers?

Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $98k median in FY2025. Base pay only — hover a year for its figures.

$40k$60k$80k$100k$120k’16’17’18’19’20’21’22’25

How has Pharmapace's H-1B hiring changed by year?

2 certified filings in FY2016 → 2 in FY2025. The change column is each year against the one before.

Pharmapace certified H-1B filings and base salary by fiscal year
Fiscal yearFilingsvs prior FYMedian base
FY20252−80%$98k
FY202210−9%$57k
FY202111+267%$83k
FY20203−25%$105k
FY20194+33%$68k
FY201830%$68k
FY20173+50%$52k
FY20162—$52k

Which wage levels does Pharmapace file?

DOL prevailing-wage levels I–IV approximate experience tiers (I = entry, IV = fully competent). 25% of Pharmapace's filings sit at Level III–IV. A heavy I–II skew reads as entry-level or contractor-style hiring; a heavy IV skew as senior in-house roles — and higher levels earn more lottery entries.

Share of 36 filings with a wage level · all years

47%
28%
25%
  • Level I47.2%17
  • Level II27.8%10
  • Level III25.0%9

What jobs does Pharmapace sponsor for H-1B?

The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.

Pharmapace most-sponsored H-1B job titles with base-salary percentiles
Job titleFilingsMedian base
Analyst/Programmer I8$57k
Analyst / Programmer I4$65k
Statistician II3$83k
Analyst/ Programmer I3$57k
Analyst/Programmer II3$68k
Senior Analyst Programmer I2$85k
Senior Manager, Clinical Programming2$93k
Manager, Statistical Programming2$105k
Senior Analyst / Programmer I2$80k
Senior Analyst/Programmer II2$110k

Where does Pharmapace hire H-1B workers?

Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.

135Certified filings (log scale)
Pharmapace H-1B worksite states
StateFilingsMedian base
CA35$68k
OR1$89k
IL1$110k
TX1$57k

What has Pharmapace filed recently?

Every certified LCA on record for Pharmapace: job title, worksite, prevailing-wage level and the offered base salary.

Pharmapace recent certified H-1B LCA filings
FYJob titleBase salary
2025Statistician II$98,000
2025IT Manager (System Engineer)$110,000
2022Analyst/Programmer I$56,534
2022Analyst/Programmer I$56,534
2022Analyst/Programmer I$56,534
2022Senior Analyst Programmer I$85,000
2022Senior Analyst Programmer I$85,000
2022Analyst/ Programmer I$56,534
2022Analyst/ Programmer I$56,534
2022Analyst/ Programmer I$56,534
2022Senior Manager, Clinical Programming$93,392
2022Senior Manager, Clinical Programming$93,392
2021Analyst/Programmer I$92,002
2021Analyst/Programmer I$92,002
2021Senior Analyst/Programmer II$110,000
2021Senior Analyst/Programmer II$110,000
2021Analyst / Programmer I$65,416
2021Statistician II$83,346
2021Analyst / Programmer I$65,416
2021Analyst / Programmer I$65,416
2021Analyst / Programmer I$65,416
2021Senior Analyst / Programmer I$89,211
2021Statistician II$83,346
2020Manager, Statistical Programming$105,000
2020Manager, Statistical Programming$105,000
2020Analyst/ Programmer II$79,000
2019Senior Analyst / Programmer I$80,441
2019Analyst/Programmer II$69,963
2019Analyst/Programmer I$57,741
2019Statistical Analyst/Programmer I$68,000
2018Sr. Statistical Analyst/Programmer I$86,000
2018Analyst/Programmer I$60,000
2018Analyst/Programmer II$67,725
2017Statistical Analyst/Coordinator$51,792
2017Analyst/Programmer II$67,829
2017Analyst/Programmer I$51,792
2016Database Analyst/Programmer I$52,104
2016Statistical Analyst II$63,440

Common questions about Pharmapace's H-1B filings

How much does Pharmapace pay H-1B workers?
Pharmapace's median certified H-1B base salary is $98k (FY2025), from 2 filings. See the full salary distribution and percentiles above.
How many H-1B workers does Pharmapace sponsor?
Pharmapace has 38 certified H-1B Labor Condition Applications on record (FY2016–FY2025).
What jobs does Pharmapace sponsor for H-1B?
Pharmapace's most-sponsored H-1B roles include Analyst/Programmer I, Analyst / Programmer I, Statistician II, Analyst/ Programmer I.
Where does Pharmapace hire H-1B workers?
Pharmapace's top H-1B worksite states are CA, OR, IL, TX.
Does a certified LCA mean an H-1B visa was approved?
No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
What salary do these figures show?
The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
What do prevailing-wage levels I–IV mean?
The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.

Keep exploring

Browse all sponsors →

Calculate your H-1B lottery odds →orCheck out the insights →

Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2016–FY2025). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →